Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gilead Sciences
(NQ:
GILD
)
72.27
-0.29 (-0.40%)
Streaming Delayed Price
Updated: 2:33 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Gilead Sciences
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Breaking Down Gilead Sciences: 10 Analysts Share Their Views
Today 12:00 EDT
Via
Benzinga
This Hidden Gem Vanguard ETF Is Chock-Full of Magnificent Stocks. Here's Why It's a Buy Now.
July 21, 2024
This fund has a basket of growth, income, and value stocks.
Via
The Motley Fool
Topics
ETFs
Check Out What Whales Are Doing With GILD
July 19, 2024
Via
Benzinga
If You Can Only Buy One Biotech Stock in July, It Better Be One of These 3 Names
July 19, 2024
Evaluating and making money from biotech stocks is incredibly difficult. These three ideas should help your quest if buying in July.
Via
InvestorPlace
Want $3,000 In Passive Income? Invest $51,000 in These 3 High-Yield Dividend Plays
July 17, 2024
These three dividend vehicles could provide reliable passive income.
Via
The Motley Fool
Gilead Sciences's Options Frenzy: What You Need to Know
July 11, 2024
Via
Benzinga
Looking Into Gilead Sciences's Recent Short Interest
July 10, 2024
Via
Benzinga
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $8,400 Today
July 09, 2024
Via
Benzinga
The 3 Most Undervalued Nasdaq 100 Stocks to Buy in July 2024
July 15, 2024
Undervalued Nasdaq 100 stocks may not be as rare as hen's teeth but not quite so plentiful amid a raging bull market.
Via
InvestorPlace
3 Dividend Growth Stocks to Buy and Hold
July 14, 2024
What's better than a dividend? A dividend that's growing.
Via
The Motley Fool
Is Iovance Biotherapeutics a Millionaire Maker?
July 14, 2024
This biotech's future is bright, but how good could it get for investors?
Via
The Motley Fool
The 7 Most Undervalued Healthcare Stocks to Buy in July 2024
July 13, 2024
Explore undervalued healthcare stocks offering growth potential and stability in contrast to overvalued tech sector.
Via
InvestorPlace
3 Underappreciated Stocks About to Break Their Chains
July 11, 2024
Explore these underappreciated stocks ready for growth and get an in-depth analysis, forecasts, and news on these potential breakout stocks.
Via
InvestorPlace
Key Takeaways From Gilead Sciences Analyst Ratings
July 01, 2024
Via
Benzinga
Gilead Sciences's Options Frenzy: What You Need to Know
June 24, 2024
Via
Benzinga
Oil Declines Amid Prospects Of An Agreement Between Israel And Hamas. Powell Will Address The Us Congress Today
July 09, 2024
On Monday, the Dow Jones (US30) decreased by 0.08%, while the S&P 500 (US500) added 0.10%. The NASDAQ Technology Index (US100) closed positive 0.28%.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
7 Cheap Biotech Stocks With Major Upside Potential
July 09, 2024
While the broader healthcare sector enjoys permanent relevance, you can potentially maximize your upside with cheap biotech stocks.
Via
InvestorPlace
Healthcare Stocks Continue To Lag The Market-Can Anything Help ?
July 08, 2024
Healthcare stocks continue to lag the market up about 6% YTD, helped by Large Cap Biopharma but hurt by United Health.
Via
Talk Markets
This Domino's Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
July 08, 2024
Via
Benzinga
Amgen, Inc. Dividend Stock Analysis
July 05, 2024
Amgen Inc. is one of the world's leading biotech companies with major treatments for anemia, neutropenia, rheumatoid and psoriatic arthritis, psoriasis, cancer and osteoporosis.
Via
Talk Markets
FDA Favorites: 3 Biotech Stocks on the Verge of Major Approvals
July 04, 2024
Biotech stocks are on the verge of a comeback after a period of underperformance amid a wave of FDA approvals.
Via
InvestorPlace
Exposures
Product Safety
3 Undervalued Biotech Gems With 200%+ Analyst Price Targets
July 04, 2024
These three undervalued biotech stocks have begun garnering investor attention as their treatments show promise.
Via
InvestorPlace
3 Magnificent Stocks Retirees Can Buy and Hold Forever
July 01, 2024
These stocks could be ideal for investors in their golden years.
Via
The Motley Fool
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields
June 28, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
June 25, 2024
Via
Benzinga
7 Dividend Stocks to Buy Now: June 2024
June 23, 2024
These dividend stocks to buy now will reward investors with income now and growth as the market breadth expands.
Via
InvestorPlace
DraftKings And Dell Were Among The 10 Biggest Large Cap Stock Gainers Last Week (June 16-June 22): Are These In Your Portfolio?
June 23, 2024
Top performers last week were SRPT (+29.50%), SIRI (+16.73%), TOST (+15.57%), GILD (+12.62%), CHWY (+10.59%), ACN (+9.80%), DKNG (+9.69%), DELL (+8.19%), ADSK (+7.99%), and GFI (+7.15%).
Via
Benzinga
Top Analyst Reports For Abbott, BP & Gilead
June 21, 2024
Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories, BP p.l.c.and Gilead Sciences, Inc., as well as two micro-cap stocks Smith-Midland Corp. and...
Via
Talk Markets
Nvidia Snaps 8-Week Winning Run, S&P 500 Marks Longest Streak Without A 2% Drop Since Great Recession, Oil Prices Stage Comeback: This Week In The Market
June 21, 2024
Stock market rally continues with new highs in S&P 500 and Nasdaq 100, driven by tech and semiconductor sectors, but concerns arise over lack of broad participation and high concentration in mega-cap...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Economy
US Equities
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
June 21, 2024
Gilead Sciences faces Wall Street speculation about its potential in the obesity drug market despite its focus on liver treatments.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.